Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072
Clinical trial NCT03632668 · COMPLETED
Trial details
- NCT number
- NCT03632668
- Sponsor
- Addpharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-28
- Primary completion
- 2019-01-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.